XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net (loss) income $ (4,610,000) $ 1,681,000 $ (16,100,000)
Adjustments to reconcile net loss to cash used in operating activities:      
Change in fair value of common stock warrant liabilities   (322,000)  
Change in fair value of contingent consideration (31,000) (140,000)  
Issuance and offering costs   769,000  
Depreciation 149,000 236,000  
Amortization of intangible assets 13,000 20,000  
Lease amortization 166,000 289,000  
Gain on disposal of property and equipment (328,000)    
Stock-based compensation 260,000 325,000  
Unrealized gain on corporate securities   (7,463,000)  
Impairment of property and equipment   210,000  
Write-down of inventory 368,000 160,000  
Changes in operating assets and liabilities:      
Accounts receivable (1,398,000) (293,000)  
Inventories 669,000 184,000  
Prepaid expenses and other current assets 208,000 (90,000)  
Other noncurrent assets 22,000    
Accounts payable and accrued expenses (198,000) (591,000)  
Amounts due to related parties 5,000 (54,000)  
Unearned revenue   55,000  
Other current liabilities   3,000  
Operating lease payments (180,000) (272,000)  
Net cash used in operating activities (4,885,000) (4,707,000) (25,900,000)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Proceeds from sale of property and equipment 787,000    
Purchases of property and equipment (40,000) (485,000)  
Net cash provided by (used in) investing activities 747,000 (485,000)  
CASH FLOWS FROM FINANCING ACTIVITIES:      
Principal payments on debt   (2,009,000)  
Proceeds from ESPP purchases 4,000 21,000  
Capital contributions received from non-controlling interest   750,000  
Net cash provided by financing activities 4,000 21,997,000  
Net (decrease) increase in cash and cash equivalents (4,134,000) 16,805,000  
Cash and cash equivalents - beginning of period 28,685,000 16,043,000 16,043,000
Cash and cash equivalents - end of period 24,551,000 32,848,000 $ 28,685,000
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:      
Cash paid for interest 1,000 19,000  
NONCASH INVESTING AND FINANCING ACTIVITIES:      
Purchases of fixed assets included in accounts payable and accrued expenses 25,000    
January 2021 PIPE Purchase Agreement [Member]      
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from issuance of common stock and warrants from offering   25,147,000  
Payments of offering costs   (1,912,000)  
NONCASH INVESTING AND FINANCING ACTIVITIES:      
Common stock warrants issued to placement agent and included in offering costs related to purchase agreement   $ 942,000  
Accounting Standards Update 2020-06 [Member]      
NONCASH INVESTING AND FINANCING ACTIVITIES:      
Common stock warrant liabilities reclassified to equity $ 3,392,000